Rise in R & D Funding by Private Organisations to Propel Growth of the Global Bo
Posted by Arslan on April 15th, 2019
A latest report by Fact.MR projects the bone growth stimulators market to account for revenues worth US$ 1,477.2 Mn in 2017. The market is estimated to exhibit a steady expansion during the forecast period. Various devices are developed for bone growth stimulation therapy, which are being highly demanded on the back of growing cases of accidental bone injuries across the globe.
Leading players in the market have introduced novel bone growth stimulators in order to cater demand from soaring adoption of affordable minimally-invasive surgeries (MIS). Orthofix, a Texas Company, has introduced new bone growth stimulators, the CervicalStim and the SpinalStim, which have been approved by the European CE Mark as well as the Food and Drug Administration of the U.S.
Ossatec Benelux B.V., Elizur Corporation, Johnson & Johnson, Arthrex, Inc., DJO Global Inc., Stryker Corporation, Bioventus Inc., Zimmer Biomet Holdings, Inc.,
Request For Sample Report-
The Market is segmented on the basis of product, End-User, & Aplication:
By End User
The Fact.MR study provides comprehensive information about growth prospects of the Bone Growth Stimulator Market. global bone growth stimulators market covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, the competitive analysis includes the in-depth analysis of the major players and leaders in virgin coconut oil industry. The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler and others. Our primary research team conducted various interviews, surveys and group discussions of industry professionals, virgin coconut oil manufacturers, aftermarket vendors and component suppliers to analyze the future prospects of the overall Market.
North America to Remain Dominant in the Global Bone Growth Stimulator Market
North America will continue to be dominant in the global bone growth stimulator market. Sales of bone growth stimulators are expected to account for the largest revenues in North America, expanding at the highest CAGR through 2022. Europe will remain the second most lucrative market for bone growth stimulators. The market in Middle East & Africa (MEA) will continue to register a sluggish expansion through 2022.
Based on end-users, sales of bone growth stimulators in academic and research institutes are expected to register the highest CAGR through 2022. Hospitals & Clinics will continue to be the largest end-users of bone growth stimulators, accounting for the highest share of the market over the forecast period. Home care is expected to remain the second most lucrative end-use segment in the global bone growth stimulators market.
“Global-Bone Growth Stimulator Market Report” has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the market space. The report also includes Porter's five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global virgin coconut oil market report also recognizes value chain analysis to understand the cost differentiation to provide the competitive advantage to the existing and new entry players.
Also See: Growth Stimulators, Bone Growth, Stimulator Market, Growth Stimulator, Stimulators, Market, Growth
Federal Funding Programs
Each year billions of dollars are distributed to the general public through government, federal and private funding programs in the form of grants, low interest and no- interest loans. Click to learn more about these programs!